Tahir Mahmood

Tahir Mahmood

CEO & Co-founder, Applied Molecular Transport and MiNDERA

Life Sciences Company Creation

Tahir is co-founder and CEO at Applied Molecular Transport, a South San Francisco-based venture-backed biotech that has taken novel scientific concepts in mucosal immunology from hypothesis to clinical trials in immunological and inflammatory disease, as well as building pipeline of drugs with applications across autoimmune, liver and metabolic diseases. With a career that has straddled science and business, he previously led the US West Coast Life Sciences consulting practice at Booz Allen Hamilton and was Managing Director at Lake Sherwood Partners. As a consultant, he advised executives across the spectrum of life sciences, healthcare provider, private and public equity investment, and global health organizations. 

Tahir is also co-founder and board director of MiNDERA, a non-invasive skin genomics and large-scale analytics company building clinical and consumer-focused products based on a technology platform he co-invented and developed as investigator at The Scripps Research Institute (La Jolla, CA). He previously served as Principal Business Analyst at Amgen, supporting business development, M&A and strategic venture fund transactions. Earlier, he was at Chienna (acquired by OctoPlus) and IsoTis S.A. (acquired by Integra Life Sciences). Tahir has authored numerous peer-reviewed publications and is inventor on multiple issued and pending patents.